New oral biologic MB-001 passes early safety check in healthy volunteers
NCT ID NCT06363383
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 28 times
Summary
This early-stage study tested whether an experimental oral drug called MB-001 is safe in healthy adults. 48 participants received either the drug or a placebo in single or multiple doses. Researchers monitored side effects and checked vital signs, lab results, and heart activity. The goal was to gather safety data before testing the drug in people with ulcerative colitis.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ULCERATIVE COLITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CMAX
Adelaide, South Australia, 5000, Australia
Conditions
Explore the condition pages connected to this study.